| Hannah Blaske, | |
|
1700 N Division St Ste 200, Davenport, IA 52804-3535 | |
| (563) 324-2263 | |
| Not Available |
| Full Name | Hannah Blaske |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 3 Years |
| Location | 1700 N Division St Ste 200, Davenport, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053070912 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians' Clinic Of Iowa, Pc | 2163325242 | 115 |
News Archive
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced the publication of an article in the December issue of Reproductive BioMedicine Online (www.rbmonline.com) about miscarriage rates following IVF treatment with frozen thawed embryos which may revolutionize clinical and laboratory practice.
Our ability to predict who will get cancer, how a patient will respond to treatment, or if a patient will relapse is still quite limited. Despite advances in the detection of genetic mutations and the establishment of risk factors, such as age and genetic variants, it remains a great scientific and medical challenge.
Johnson & Johnson's Tibotec Pharmaceuticals unit on Thursday announced it had granted multiple licenses to generic drug manufacturers "to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if it's approved by regulators," Bloomberg Businessweek reports.
› Verified 8 days ago
| Provider Name | Physicians' Clinic Of Iowa, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821075599 PECOS PAC ID: 2163325242 Enrollment ID: O20040128000886 |
News Archive
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced the publication of an article in the December issue of Reproductive BioMedicine Online (www.rbmonline.com) about miscarriage rates following IVF treatment with frozen thawed embryos which may revolutionize clinical and laboratory practice.
Our ability to predict who will get cancer, how a patient will respond to treatment, or if a patient will relapse is still quite limited. Despite advances in the detection of genetic mutations and the establishment of risk factors, such as age and genetic variants, it remains a great scientific and medical challenge.
Johnson & Johnson's Tibotec Pharmaceuticals unit on Thursday announced it had granted multiple licenses to generic drug manufacturers "to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if it's approved by regulators," Bloomberg Businessweek reports.
› Verified 8 days ago
| Provider Name | Rock Valley Physical Therapy Center |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1245373166 PECOS PAC ID: 9638087877 Enrollment ID: O20080513000596 |
News Archive
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced the publication of an article in the December issue of Reproductive BioMedicine Online (www.rbmonline.com) about miscarriage rates following IVF treatment with frozen thawed embryos which may revolutionize clinical and laboratory practice.
Our ability to predict who will get cancer, how a patient will respond to treatment, or if a patient will relapse is still quite limited. Despite advances in the detection of genetic mutations and the establishment of risk factors, such as age and genetic variants, it remains a great scientific and medical challenge.
Johnson & Johnson's Tibotec Pharmaceuticals unit on Thursday announced it had granted multiple licenses to generic drug manufacturers "to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if it's approved by regulators," Bloomberg Businessweek reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hannah Blaske, 850 43rd Ave Ste 100, Moline, IL 61265-8401 Ph: (309) 743-2070 | Hannah Blaske, 1700 N Division St Ste 200, Davenport, IA 52804-3535 Ph: (563) 324-2263 |
News Archive
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced the publication of an article in the December issue of Reproductive BioMedicine Online (www.rbmonline.com) about miscarriage rates following IVF treatment with frozen thawed embryos which may revolutionize clinical and laboratory practice.
Our ability to predict who will get cancer, how a patient will respond to treatment, or if a patient will relapse is still quite limited. Despite advances in the detection of genetic mutations and the establishment of risk factors, such as age and genetic variants, it remains a great scientific and medical challenge.
Johnson & Johnson's Tibotec Pharmaceuticals unit on Thursday announced it had granted multiple licenses to generic drug manufacturers "to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if it's approved by regulators," Bloomberg Businessweek reports.
› Verified 8 days ago
Muna Majdi Omar, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 5254 Utica Ridge Rd, Davenport, IA 52807 Phone: 563-359-3799 | |
Ms. Sara Katherine Petersen, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1008 W 35th St, Davenport, IA 52806 Phone: 563-362-0060 | |
Joel D Mason, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3385 Dexter Ct, Plaza Physical Therapy, Davenport, IA 52807 Phone: 563-344-6645 Fax: 563-441-7796 | |
Quad City Physical Therapy & Spine Physical Therapist Medicare: Medicare Enrolled Practice Location: 5254 Utica Ridge Rd, Davenport, IA 52807 Phone: 563-359-3799 Fax: 563-359-3804 | |
Mr. Michael Leonard Puthoff, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 518 W Locust St, Physical Therapy Department, Davenport, IA 52803 Phone: 563-333-6009 | |
Randall E Boldt, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1008 W 35th St, Davenport, IA 52806 Phone: 563-324-2263 Fax: 563-324-0719 | |
Elizabeth A Miller, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3385 Dexter Ct, Ste 301, Davenport, IA 52807 Phone: 563-344-6645 Fax: 563-441-7796 |